Cargando…

The impact of the metabolic phenotype on thyroid function in obesity

BACKGROUND: Obesity is known to promote mild hyperthyrotropinaemia by unknown metabolic mechanisms. This investigation aimed to explore the association between thyroid function and metabolic phenotype in euthyroid obese individuals. Retrospective, cross-sectional study. Tertiary care center. METHODS...

Descripción completa

Detalles Bibliográficos
Autores principales: Marzullo, Paolo, Mele, Chiara, Mai, Stefania, Guzzaloni, Gabriele, Soranna, Davide, Tagliaferri, Maria Antonella, Berselli, Maria Elisa, Prodam, Flavia, Surico, Daniela, Aimaretti, Gianluca, Scacchi, Massimo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995618/
https://www.ncbi.nlm.nih.gov/pubmed/27559364
http://dx.doi.org/10.1186/s13098-016-0177-x
_version_ 1782449506114076672
author Marzullo, Paolo
Mele, Chiara
Mai, Stefania
Guzzaloni, Gabriele
Soranna, Davide
Tagliaferri, Maria Antonella
Berselli, Maria Elisa
Prodam, Flavia
Surico, Daniela
Aimaretti, Gianluca
Scacchi, Massimo
author_facet Marzullo, Paolo
Mele, Chiara
Mai, Stefania
Guzzaloni, Gabriele
Soranna, Davide
Tagliaferri, Maria Antonella
Berselli, Maria Elisa
Prodam, Flavia
Surico, Daniela
Aimaretti, Gianluca
Scacchi, Massimo
author_sort Marzullo, Paolo
collection PubMed
description BACKGROUND: Obesity is known to promote mild hyperthyrotropinaemia by unknown metabolic mechanisms. This investigation aimed to explore the association between thyroid function and metabolic phenotype in euthyroid obese individuals. Retrospective, cross-sectional study. Tertiary care center. METHODS: 952 euthyroid obese individuals referred to our Institution for obesity. Serum levels of TSH, FT4, glucose, insulin and HbA1c levels, lipid profile, liver function and proinflammatory indices were measured. Resting energy expenditure was assessed by indirect calorimetry and body composition by bioimpedance analysis. RESULTS: On admission, 306 patients had previously diagnosed diabetes mellitus on treatment with metformin, while 113 patients were diagnosed with incident diabetes mellitus. Serum TSH levels were similar between metformin-treated diabetic subjects and metformin-untreated subjects, while FT4 was slightly but significantly higher in the former. Analysis stratified by TSH categories found no effect of metformin-treated diabetes mellitus on TSH levels. Interestingly, obese patients with incident diabetes showed lower TSH levels than normoglycaemic ones. In correlation studies on the whole dataset, an association related TSH to BMI and total cholesterol levels, which was lost upon adjustment for individual confounders. FT4 levels were found to be inversely related to BMI, insulin resistance and triglycerides, while being directly associated with HDL-cholesterol levels. These correlations remained unaltered after controlling for individual confounders. In multivariate linear regression analysis, TSH was associated with FT4, total cholesterol and BMI values. Significant predictors of FT4 were constituted by previously diagnosed diabetes mellitus, BMI, TSH and age. CONCLUSIONS: In euthyroid obese subjects, FT4 seems more closely related than TSH levels to parameters of cardiometabolic risk. TSH levels did not differ between metformin-treated and untreated subjects, while they were lower in patients with incident diabetes mellitus compared to normoglycaemic ones.
format Online
Article
Text
id pubmed-4995618
institution National Center for Biotechnology Information
language English
publishDate 2016
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-49956182016-08-25 The impact of the metabolic phenotype on thyroid function in obesity Marzullo, Paolo Mele, Chiara Mai, Stefania Guzzaloni, Gabriele Soranna, Davide Tagliaferri, Maria Antonella Berselli, Maria Elisa Prodam, Flavia Surico, Daniela Aimaretti, Gianluca Scacchi, Massimo Diabetol Metab Syndr Research BACKGROUND: Obesity is known to promote mild hyperthyrotropinaemia by unknown metabolic mechanisms. This investigation aimed to explore the association between thyroid function and metabolic phenotype in euthyroid obese individuals. Retrospective, cross-sectional study. Tertiary care center. METHODS: 952 euthyroid obese individuals referred to our Institution for obesity. Serum levels of TSH, FT4, glucose, insulin and HbA1c levels, lipid profile, liver function and proinflammatory indices were measured. Resting energy expenditure was assessed by indirect calorimetry and body composition by bioimpedance analysis. RESULTS: On admission, 306 patients had previously diagnosed diabetes mellitus on treatment with metformin, while 113 patients were diagnosed with incident diabetes mellitus. Serum TSH levels were similar between metformin-treated diabetic subjects and metformin-untreated subjects, while FT4 was slightly but significantly higher in the former. Analysis stratified by TSH categories found no effect of metformin-treated diabetes mellitus on TSH levels. Interestingly, obese patients with incident diabetes showed lower TSH levels than normoglycaemic ones. In correlation studies on the whole dataset, an association related TSH to BMI and total cholesterol levels, which was lost upon adjustment for individual confounders. FT4 levels were found to be inversely related to BMI, insulin resistance and triglycerides, while being directly associated with HDL-cholesterol levels. These correlations remained unaltered after controlling for individual confounders. In multivariate linear regression analysis, TSH was associated with FT4, total cholesterol and BMI values. Significant predictors of FT4 were constituted by previously diagnosed diabetes mellitus, BMI, TSH and age. CONCLUSIONS: In euthyroid obese subjects, FT4 seems more closely related than TSH levels to parameters of cardiometabolic risk. TSH levels did not differ between metformin-treated and untreated subjects, while they were lower in patients with incident diabetes mellitus compared to normoglycaemic ones. BioMed Central 2016-08-24 /pmc/articles/PMC4995618/ /pubmed/27559364 http://dx.doi.org/10.1186/s13098-016-0177-x Text en © The Author(s) 2016 Open AccessThis article is distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated.
spellingShingle Research
Marzullo, Paolo
Mele, Chiara
Mai, Stefania
Guzzaloni, Gabriele
Soranna, Davide
Tagliaferri, Maria Antonella
Berselli, Maria Elisa
Prodam, Flavia
Surico, Daniela
Aimaretti, Gianluca
Scacchi, Massimo
The impact of the metabolic phenotype on thyroid function in obesity
title The impact of the metabolic phenotype on thyroid function in obesity
title_full The impact of the metabolic phenotype on thyroid function in obesity
title_fullStr The impact of the metabolic phenotype on thyroid function in obesity
title_full_unstemmed The impact of the metabolic phenotype on thyroid function in obesity
title_short The impact of the metabolic phenotype on thyroid function in obesity
title_sort impact of the metabolic phenotype on thyroid function in obesity
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4995618/
https://www.ncbi.nlm.nih.gov/pubmed/27559364
http://dx.doi.org/10.1186/s13098-016-0177-x
work_keys_str_mv AT marzullopaolo theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT melechiara theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT maistefania theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT guzzalonigabriele theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT sorannadavide theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT tagliaferrimariaantonella theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT bersellimariaelisa theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT prodamflavia theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT suricodaniela theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT aimarettigianluca theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT scacchimassimo theimpactofthemetabolicphenotypeonthyroidfunctioninobesity
AT marzullopaolo impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT melechiara impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT maistefania impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT guzzalonigabriele impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT sorannadavide impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT tagliaferrimariaantonella impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT bersellimariaelisa impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT prodamflavia impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT suricodaniela impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT aimarettigianluca impactofthemetabolicphenotypeonthyroidfunctioninobesity
AT scacchimassimo impactofthemetabolicphenotypeonthyroidfunctioninobesity